We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMCA
8676
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
$8.6K ﹤0.01%
+831
New +$8.53K
EGF
8677
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$8.6K ﹤0.01%
888
+882
+14,700% +$8.59K
RENEU
8678
DELISTED
Cartesian Growth Corporation II Unit
RENEU
$8.59K ﹤0.01%
840
DFEV icon
8679
Dimensional Emerging Markets Value ETF
DFEV
$2.01B
$8.59K ﹤0.01%
+380
New +$8.33K
EZRA
8680
Reliance Global Group
EZRA
$2.18M
$8.58K ﹤0.01%
1
ARMP icon
8681
Armata Pharmaceuticals
ARMP
$175M
$8.58K ﹤0.01%
6,918
+5,043
+269% +$13.1K
BRDS
8682
DELISTED
Bird Global, Inc.
BRDS
$8.56K ﹤0.01%
+1,902
New +$13.9K
SEPA
8683
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
$8.55K ﹤0.01%
+860
New +$8.61K
DVLT
8684
Datavault AI
DVLT
$265M
$8.54K ﹤0.01%
+5
New +$24.3K
ANGH icon
8685
Anghami
ANGH
$31M
$8.53K ﹤0.01%
533
+64
+14% +$1.53K
JWEL icon
8686
Jowell Global
JWEL
$4.51M
$8.52K ﹤0.01%
+1,268
New +$20.4K
PHIO icon
8687
Phio Pharmaceuticals
PHIO
$12.2M
$8.52K ﹤0.01%
+213
New +$10.9K
PAYOW
8688
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$8.51K ﹤0.01%
8,265
+4,167
+102% +$5.37K
RKLY
8689
DELISTED
Rockley Photonics Holdings Limited
RKLY
$8.51K ﹤0.01%
+60,758
New +$23.2K
ARBG
8690
DELISTED
Aequi Acquisition Corp
ARBG
$8.5K ﹤0.01%
+867
New +$8.64K
APRE icon
8691
Aprea Therapeutics
APRE
$8.08M
$8.49K ﹤0.01%
1,287
+990
+333% +$10.4K
SNTG icon
8692
Sentage Holdings
SNTG
$5.39M
$8.46K ﹤0.01%
4,406
-1,780
-29% -$4.23K
GENI.WS
8693
DELISTED
Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share
GENI.WS
$8.44K ﹤0.01%
+9,376
New +$9.21K
IXHL icon
8694
Incannex Healthcare
IXHL
$38.5M
$8.43K ﹤0.01%
25
-3
-11% -$1.37K
PRPO icon
8695
Precipio
PRPO
$44M
$8.43K ﹤0.01%
766
+238
+45% +$3.58K
GWII
8696
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
$8.42K ﹤0.01%
838
+249
+42% +$2.5K
QCLS
8697
Q/C Technologies Inc
QCLS
$23.1M
$8.41K ﹤0.01%
+2
New +$12.6K
PORT.U
8698
DELISTED
Southport Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-half of one warrant
PORT.U
$8.41K ﹤0.01%
830
BMAQ
8699
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
$8.4K ﹤0.01%
824
-852
-51% -$8.61K
BSLK
8700
DELISTED
Bolt Projects Holdings
BSLK
$8.39K ﹤0.01%
42
-353
-89% -$70.3K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.